The US Meals and Drug Administration has named Vinay Prasad, an oncologist who has beforehand criticized COVID-19 restrictions, because the director of its Middle for Biologics Analysis and Analysis, an inside electronic mail seen by Reuters stated on Tuesday.
The US FDA’s commissioner, Marty Makary, made the announcement in an electronic mail to workers.
Prasad involves the FDA from the College of California at San Francisco.
In March, Peter Marks, the FDA’s former head of the division, which regulates vaccines and biologics, was pushed out of the company.
Scott Steele, an FDA insider for the previous 5 years, had been serving as appearing head of the division after Marks’ exit.
